NASDAQ$GEHC
GE HealthCare Technologies Inc · Q2 2025 earnings
Q2 2025 earnings · · Before market open · Investor relations
Briefing
GE HealthCare Technologies Inc reported Q2 2025 revenues of $5.007 billion and net income of $500 million.
GE HealthCare delivered 3% revenue growth to $5.007 billion in Q2 2025, driven by services and the PDx segment. Operating income rose to $654 million while net income reached $500 million. The company completed the NMP acquisition, contributing to PDx performance amid ongoing tariff and China market pressures.
- Total revenues grew 3% year-over-year to $5.007 billion, with services up 7%.
- PDx segment revenues increased 14% to $729 million, aided by the NMP acquisition and 5% organic growth.
- Operating income reached $654 million, up 8% from the prior year.
- Net income attributable to GE HealthCare was $486 million, or $1.06 per diluted share.
Headline financials
Revenue & EPS history
GE HealthCare · Revenue · Quarterly
$5.01B
Revenue by segment
GE HealthCare · $5.01B total across 5 segments · Q2 2025
- Imaging$2.2B—44.0%
- Advanced Visualization Solutions$1.29B—25.7%
- Patient Care Solutions$778M—15.5%
- Pharmaceutical Diagnostics$729M—14.6%
- Other$6M—0.1%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 15 quarterly earnings reports
-0.2%
Avg return
Earnings day
+0.2%
Avg return
5 days after
-0.3%
Avg return
30 days after
50%
8 / 16 earnings
Positive
+11.5%
Q4 2021
Best reaction
-12.9%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | -12.9% | -10.9% | -8.9% | |
| Q4 2025 | +6.4% | +0.4% | -5.7% | |
| Q3 2025 | -2.7% | -6.2% | +0.7% | |
| Q1 2025 | +3.3% | +1.9% | +3.6% | |
| Q4 2024 | +8.8% | +7.9% | -4.6% | |
| Q3 2024 | +2.4% | +2.0% | -2.4% | |
| Q2 2024 | +0.9% | -1.4% | +2.6% | |
| Q1 2024 | -12.0% | -10.6% | -11.7% | |
| Q4 2021 | +11.5% | +10.8% | +26.2% | |
| Q3 2023 | +8.1% | +13.3% | +8.4% | |
| Q3 2022 | +8.1% | +13.3% | +8.4% | |
| Q2 2023 | -4.0% | -3.4% | -15.1% | |
| Q1 2023 | -8.7% | -7.3% | -9.0% | |
| Q1 2022 | -8.7% | -7.3% | -9.0% | |
| Q2 2022 | -2.3% | +0.8% | +4.4% | |
| Q4 2022 | -0.8% | +0.7% | +7.4% | |
| Q3 2021 | — | — | — | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro